Built for 𝕏∙LinkedIn∙Bluesky∙Threads. Powered by AI
Write & schedule, effortlessly
Craft and publish engaging content in an app built for creators.
NEW
Publish anywhere
Publish on X, LinkedIn, Bluesky, Threads, & Mastodon at the same time.
Make it punchier 👊
Typefully
@typefully
We're launching a Command Bar today with great commands and features.
AI ideas and rewrites
Get suggestions, tweet ideas, and rewrites powered by AI.
Turn your tweets & threads into a social blog
Give your content new life with our beautiful, sharable pages. Make it go viral on other platforms too.
+14
Followers
Powerful analytics to grow faster
Easily track your engagement analytics to improve your content and grow faster.
Build in public
Share a recent learning with your followers.
Create engagement
Pose a thought-provoking question.
Never run out of ideas
Get prompts and ideas whenever you write - with examples of popular tweets.
@aaditsh
I think this thread hook could be improved.
@frankdilo
On it 🔥
Share drafts & leave comments
Write with your teammates and get feedback with comments.
NEW
Easlo
@heyeaslo
Reply with "Notion" to get early access to my new template.
Jaga
@kandros5591
Notion 🙏
DM Sent
Create giveaways with Auto-DMs
Send DMs automatically based on engagement with your tweets.
And much more:
Auto-Split Text in Posts
Thread Finisher
Tweet Numbering
Pin Drafts
Connect Multiple Accounts
Automatic Backups
Dark Mode
Keyboard Shortcuts
Creators love Typefully
180,000+ creators and teams chose Typefully to curate their Twitter presence.
Marc Köhlbrugge@marckohlbrugge
Tweeting more with @typefully these days.
🙈 Distraction-free
✍️ Write-only Twitter
🧵 Effortless threads
📈 Actionable metrics
I recommend giving it a shot.
Jurre Houtkamp@jurrehoutkamp
Typefully is fantastic and way too cheap for what you get.
We’ve tried many alternatives at @framer but nothing beats it. If you’re still tweeting from Twitter you’re wasting time.
DHH@dhh
This is my new go-to writing environment for Twitter threads.
They've built something wonderfully simple and distraction free with Typefully 😍
Santiago@svpino
For 24 months, I tried almost a dozen Twitter scheduling tools.
Then I found @typefully, and I've been using it for seven months straight.
When it comes down to the experience of scheduling and long-form content writing, Typefully is in a league of its own.
Luca Rossi ꩜@lucaronin
After trying literally all the major Twitter scheduling tools, I settled with @typefully.
Killer feature to me is the native image editor — unique and super useful 🙏
Visual Theory@visualtheory_
Really impressed by the way @typefully has simplified my Twitter writing + scheduling/publishing experience.
Beautiful user experience.
0 friction.
Simplicity is the ultimate sophistication.
Queue your content in seconds
Write, schedule and boost your tweets - with no need for extra apps.
Schedule with one click
Queue your post with a single click - or pick a time manually.
Pick the perfect time
Time each post to perfection with Typefully's performance analytics.
Boost your content
Retweet and plug your posts for automated engagement.
Start creating a content queue.
Write once, publish everywhere
We natively support multiple platforms, so that you can expand your reach easily.
Check the analytics that matter
Build your audience with insights that make sense.
Writing prompts & personalized post ideas
Break through writer's block with great ideas and suggestions.
Never run out of ideas
Enjoy daily prompts and ideas to inspire your writing.
Use AI for personalized suggestions
Get inspiration from ideas based on your own past tweets.
Flick through topics
Or skim through curated collections of trending tweets for each topic.
Write, edit, and track tweets together
Write and publish with your teammates and friends.
Share your drafts
Brainstorm and bounce ideas with your teammates.
NEW
@aaditsh
I think this thread hook could be improved.
@frankdilo
On it 🔥
Add comments
Get feedback from coworkers before you hit publish.
Read, Write, Publish
Read, WriteRead
Control user access
Decide who can view, edit, or publish your drafts.
Change My Mind:
I do not support waiting for a blinded randomized placebo-controlled monkeypox trial before expanding access to tecovirimat(TPOXX).
Despite being an online educator and supporter of evidence-based medicine. Is my thinking wrong? 💬
(And lest I be called out: it's also because TPOXX appears to be very safe and well-tolerated.) Main side effect in the TPOXX trial? Nausea, which is an extremely common side effect of many drugs, and usually easy to manage. Here's the list:
And of course we don't know about long-term risks or side effects, or effects in the larger population. But we don't know that of *any* drug after an randomized trial —which is why the FDA has Phase 4 of Drug Monitoring: once approved, drug side effects are still reported.
I should also add that the anecdotal data on TPOXX is also compelling. (Yes I'm aware that the plural of anecdote is not data).
Look at these recovery photos starting pre, day4, day7 TPOXX:
Yes, randomized controlled trials (RCT) are the best evidence that Drug A caused outcome X. And for COVID interventions—vaccines, paxlovid, steroids, etc—I demanded them. (I commonly speak out that Paxlovid has not been shown to help vaccinated people, for example.)
But we have other types of studies and evidence. They're not as strong of evidence, but: they exist because for one reason or another, conditions in our world don't make an RCT appropriate.
And for me, this is the clincher: we are in another pandemic. But THIS TIME, we ALREADY have something that could stop it from spreading more widely, say to children. Or to colleges. Or to jails.
Look at that 🇺🇸 line I highlighted: WE ARE RAPIDLY CATCHING UP IN PER-CAPITA CASES.
Finally, I'll admit my bias: this is personal and emotional. I'm a gay ER doctor in SF.
—This is pandemic #2
—I've treated MPX patients my same age
—I have seen genital lesions so upsetting and intrusive that I have had counseling on how to erase them from my mind.
So please, tell me if my thinking is wrong. Sure, ideally we'd do an RCT. But is it really worth waiting 6-9 months for a trial to get published when TODAY we have less than 10,000 monkeypox cases in this country? Because 11 days ago, we only had 5,000.
I'll let you do the math.
And you know what? We already have PLENTY of placebo controls for any trial that needs them. They're called "gay men with monkeypox who we wouldn't treat."
We need expanded TPOXX access now. We need an emergency use authorization.